Infectious Disease Testing
Molecular diagnostic testing delivers increased speed and accuracy over traditional culture methods.
- Rapid pathogen detection for faster treatment
- Identifies polymicrobial infections
- More accurate than traditional culture methods
- Delivers actionable treatment guidance by identifying antibiotic resistance genes
Our Test Offerings
COVID-19 PCR Testing
An FDA-compliant COVID-19 reverse-transcription polymerase chain reaction (RT-PCR) test for quick SARS-CoV-2 identification, enabling faster treatment.
COVID-19 + Flu Combo Testing
Combines a gold-standard COVID-19 RT-PCR test with an influenza A + B panel to help identify individuals with co-infections and distinguish between influenza and COVID-19 cases.
Gastrointestinal Pathogen Panel Testing (GI)
Detects enteropathogenic viruses, bacteria, and parasites causing gastroenteritis and antibiotic drug resistance through multiplex quantitative RT-PCR.
Influenza A+B Testing (Flu)
Uses RT-PCR testing to detect both A & B influenza virus strains quickly.
Nail Pathogen Panel Testing (NPP)
Identifies fungal and bacterial microbial toenail infections and antibiotic resistance genes with RT-PCR testing for superior precision and speed over traditional cultures.
Respiratory Pathogen Panel Testing (RPP)
Rapidly detects and differentiates a wide range of viral and bacterial pathogens.
AccessDx UTI PROx Panel
UTI PROx panel combines RT-PCR and culture to rapidly detect uropathogens and coinfections while improving treatment speed, efficacy, and antibiotic stewardship.
Wound Pathogen Panel Testing (WPP)
Identifies fungal and bacterial microbial wound infections with molecular analysis for superior precision and speed in species and antibiotic resistance gene identification over traditional cultures.